You must install Adobe Flash to view this content.


AccuTheranostics is dedicated to providing and discovering breakthrough cancer diagnostics that will dramatically improve the lives of patients suffering from a wide array of cancers. We also provide R&D services that will improve drug development for the Biotech and Pharmaceutical industries.

AccuTheranostics, Inc. provides clinical laboratory services that improve currently available chemotherapy cancer treatment options available to the physician and patient, and also enable the pharmaceutical industry to more rapidly and cost-effectively develop new cancer treatment drugs.

Your physician can directly order AccuTheranostics' laboratory tests if he or she has determined that the Chemoresistance/ Sensitivity Assay or other AccuTheranostics cancer testing services are right for you.



ChemoFit™ is the most advanced chemotherapy resistance and sensitivity test available today.  It allows you to test potential chemotherapy treatments on your cancer prior to treating your body.

Chemofit Information


Cancer Patients' Guide

A summary of current cancer treatment options, including: surgical, radiation, chemotherapy and experimental cancer treatments.

Explore the specific cancer treatment resources of interest to you, and then contact your doctor to discuss your best options.

Click to View


New Publication

New reseach at AccuTheranostics:  Individualizing Chemotherapy using the Anti-Diabetic Drug, Metformin, as an “Adjuvant”: An Exploratory Study

Journal of Cancer Science & Therapy

For Canadian Patients

Medicor Cancer Centres, Inc.
4576 Yonge Street, Suite 412
Toronto, ON Canada M2N 6N4
(416) 227-0037


Other Resources

"Hope for Two" the Pregnant
With Cancer Network